Matches in Nanopublications for { <http://purl.org/np/RA2-dISS3g4AXlPLECdvCYWNM2vSt8CBR6UHbVdQrBTHw#assertion> ?p ?o ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion wasAttributedTo 0000-0002-3668-2627 provenance.
- assertion generatedAtTime "2022-10-13T11:44:43.063138" provenance.
- assertion wasQuotedFrom " Nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. The largest and most consistent cardiovascular outcome benefit has been a reduction in stroke. There are no controlled trials demonstrating risk reduction with nebivolmolol tablets. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients. " provenance.